The FDA Black Box Warning: Why Vaginal Estrogen Deserves Freedom

Send us Fan MailThe FDA is considering removing the black box warning from low-dose vaginal estrogen products following a unanimous opinion from an expert advisory panel that risks have been overstated for years.• Vaginal estrogen is a local, low-dose treatment that stays in the vagina with minimal systemic absorption• The black box warning came from the 2002 Women's Health Initiative study that incorrectly applied systemic hormone risks to all estrogen products• 72% of sepsis cases in older women could potentially be prevented with vaginal estrogen use• Vaginal estrogen helps restore tissue elasticity, prevent UTIs, and protect the urethra• Even women on systemic hormone therapy may need vaginal estrogen as the "vagina is her own little desert island"• Application tip: use your finger to swirl the cream around rather than just using the applicator to prevent leakage• Treatment regimen is typically twice weekly (like "Monday and Thursday vagina spa nights")• Results may take up to three months to be fully noticeable• Removing the warning could help more women access this beneficial treatmentJoin us in our private Facebook group, the Pause Diaries, a safe, supportive space where we talk openly about perimenopause, menopause, and all the changes that come with it.Loved this conversation? Let’s keep it going. Join our private Facebook group, The Pause Diaries, where we dive deeper into all things perimenopause and menopause—without judgment, just real talk.If this episode inspired you, share it with a friend or colleague. And don’t forget to subscribe, rate, and review The Pause Podcast—your support helps us bring more expert voices to the table. Got a story, symptom, or question? Send it my way at by posting it our Facebook Group The Pause Diaries that supports the podcast. I just might feature it in an upcoming episode!Until next time, stay curious, stay empowered, and never hit pause on your wellbeing.